Esophageal Diseases  >>  cabazitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cabazitaxel / Generic mfg.
NCT01757171: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma

Completed
2
85
US
Cabazitaxel
Weill Medical College of Cornell University, Sanofi
Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, Distal Esophageal Adenocarcinoma
07/16
06/17

Download Options